Reducing resistance may require more than cutting antibiotic use alone.
US COVID-19 vaccine disparities (CVD) were linked with income, education, political views, and race, according to a study yesterday in the Proceedings of the National Academy of Sciences.
While Latino people have lower rates of mortality despite their higher rates of poverty compared with White people in the United States, the COVID-19 pandemic erased it, at least in Los Angeles County, according to a JAMA research letter yesterday.
Half of patients hospitalized with severe COVID-19 across 302 UK hospitals developed one or more health complications within 28 days or discharge, according to a study yesterday in The Lancet.
CARB-X announced today that it is awarding up to $3.9 million to a Danish microbiome biotechnology company to develop a CRISPR-based drug to prevent Escherichia coli infections in cancer patients.
One in three COVID-19 survivors were diagnosed as having a neurologic or psychological condition within 6 months after their coronavirus diagnosis, according to a study yesterday in The Lancet Psychiatry. The researchers noted that disease severity was linked to higher risk.
The National Institute of Allergy and Infectious Diseases (NIAID) announced yesterday that it has awarded $2.5 million in grants to support research on bacteriophage therapy.
Higher viral loads of SARS-CoV-2, the virus that causes COVID-19, are associated with an increased risk of transmission, according to cohort study results from Catalonia, Spain, published yesterday in The Lancet Infectious Diseases,
A coalition of animal welfare, public health, environmental, and consumer organizations is speaking out against use of the One Health Certified (OHC) label on chicken and turkey products, claiming the standards behind the label don't protect against overuse of medically important antibiotics in food-producing animals.
A new study led by researchers with Pfizer shows a substantial burden of extraintestinal invasive Escherichia coli infections (IEIs) in the United States, with increasing resistance to extended-spectrum cephalosporins.